Search Orphan Drug Designations and Approvals
-
| Generic Name: | elraglusib |
|---|---|
| Date Designated: | 07/03/2024 |
| Orphan Designation: | treatment of soft tissue sarcomas |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Actuate Therapeutics, Inc. 1751 River Run, Suite 400 Fort Worth, Texas 76107 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







